T 0367/95 (Antihemophilic factor/PHARMACIA) of 27.10.1998
- European Case Law Identifier
- ECLI:EP:BA:1998:T036795.19981027
- Date of decision
- 27 October 1998
- Case number
- T 0367/95
- Petition for review of
- -
- Application number
- 86850067.9
- IPC class
- C07K 15/12
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
- Applicant name
- Pharmacia & Upjohn Aktiebolag
- Opponent name
- Immuno Aktiengesellschaft
Rhone-Poulenc Rorer, Inc
Novo Nordisk A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973
- Keywords
- Amendment - extension of protection conferred (no)
Amendment - added subject-matter (no)
Novelty (yes)
Remittal - Catchword
- -
- Cited cases
- G 0004/92
- Citing cases
- T 0029/99
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance for further prosecution of the main request for non-AT states, as filed on 29 June 1995.